(Q47981050)

7 February 2018

title

Marked Hyperlipidemia and Pancreatitis Associated with Oral Contraceptive Therapy (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

24 February 2023

1 reference

F. Davidoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4723103

24 February 2023

S. Tishler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4723103

24 February 2023

C. Rosoff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4723103

24 February 2023

language of work or name

English

0 references

publication date

1 September 1973

1 reference

7 February 2018

13 September 1973

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4723103

full work available at URL

24 February 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197309132891103

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

The New England Journal of Medicine

24 February 2023

published in

1 reference

7 February 2018

volume

289

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

page(s)

552-555

1 reference

7 February 2018

Fasting serum triglyceride, cholesterol, and lipoprotein levels during oral-contraceptive therapy.

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Serum-lipids in women on oral contraceptives.

24 February 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Oral contraceptives and serum lipids

24 February 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Plasma triglyceride turnover during use of oral contraceptives

24 February 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives

24 February 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Case reports. Hyperlipaemic pancreatitis and the pill

24 February 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Some effects of oral contraceptives on carbohydrate metabolism.

24 February 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Cross-sectional investigation of carbohydrate metabolism in women taking a sequential or combination type oral contraceptive: measurements of blood glucose, plasma insulin and plasma growth hormone during an oral glucose tolerance test

24 February 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Oral contraceptives and triglyceride transport: acquired heparin resistance as the mechanism for impaired post-heparin lipolytic activity.

24 February 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Dietary and drug treatment of primary hyperlipoproteinemia

24 February 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia

24 February 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons

24 February 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197309132891103

24 February 2023

Identifiers

1 reference

7 February 2018

release_ivyxeaw63rb6dj7awp6wwh4peu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ivyxeaw63rb6dj7awp6wwh4peu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

7 February 2018